Moreover, we revealed that CCT2 contributes to breast cancer immune evasion by packaging into breast cancer cell-derived exosomes, where it regulates CD4+ T cell activation through the Ca2+-NFAT1 pathway. The gene discussed is CD4; the disease is breast carcinoma.